IP Verse

Akebia Therapeutics, Inc. opposition analysis

COMPANY ANALYSIS

Latest oppositions filed by Akebia Therapeutics, Inc.

Patent Number:
EP2324834
Title:
Methods Of Increasing Endogenous Erythropoietin (Epo)
Applicant:
FIBROGEN, INC.
Opposition Date:
Feb 10, 2020
Patent Number:
EP2289531
Title:
Medicaments For Increasing Endogenous Erythropoietine (Epo)
Applicant:
FIBROGEN, INC.
Opposition Date:
Apr 3, 2019
Patent Number:
EP2298301
Title:
Medicaments For Increasing Endogenous Erythropoietin (Epo)
Applicant:
FIBROGEN, INC.
Opposition Date:
Apr 3, 2019
Patent Number:
EP2322153
Title:
Use Of Hif Alpha Stabilizers For Enhancing Erythropoiesis
Applicant:
FIBROGEN, INC.
Opposition Date:
Jul 6, 2015

Latest patents of Akebia Therapeutics, Inc. opposed by its competitors

Patent:
EP3277270
Grant Date:
Oct 27, 2021
Title:
Compositions And Methods For Treating Anemia
Oppositions:
1

Competitors of Akebia Therapeutics, Inc.

FIBROGEN, INC.

SANDOZ AG

Want to track Akebia Therapeutics, Inc.?

Feel free to send us a message here and we will get back to you